BTG1 Might Be Employed as a Biomarker for Carcinogenesis and a Target for Gene Therapy in Colorectal Cancers
Oncotarget - United States
doi 10.18632/oncotarget.10649
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 18, 2016
Authors
Publisher
Impact Journals, LLC